First-Line Treatment of HER2-Positive Metastatic Breast Cancer

2 Visningar
administrator
administrator
07/03/23

Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community

  • Kategori

Visa mer

0 Kommentarer Sortera efter

Inga kommentarer hittades

Facebook-kommentarer

Strax